Cambiar Investors’s AstraZeneca AZN Stock Holding History

Cambiar Investors’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$24.6M	Sell	129,899 -3,700	-3%	-$696K	1.07%	43
2026 Q1	$26.3M	Sell	133,599 -4,476	-3%	-$863K	1.22%	38
2025 Q4	$25.4M	Buy	138,075 +2,663	+2%	+$467K	1.13%	39
2025 Q3	$20.8M	Sell	135,412 -230	-0.2%	-$34.8K	0.94%	41
2025 Q2	$19M	Buy	+135,642	New	+$19M	0.8%	39
2016 Q4	–	Sell	-2,254,023	Closed	-$148M	–	158
2016 Q3	$148M	Sell	2,254,023 -1,425,872	-39%	-$93.2M	2.16%	11
2016 Q2	$222M	Buy	3,679,895 +21,145	+0.6%	+$1.23M	3.15%	3
2016 Q1	$206M	Buy	3,658,750 +227,432	+7%	+$13.7M	2.96%	3
2015 Q4	$233M	Buy	3,431,318 +617,274	+22%	+$40.5M	3.35%	1
2015 Q3	$179M	Buy	2,814,044 +708,131	+34%	+$46.6M	2.64%	1
2015 Q2	$134M	Buy	+2,105,913	New	+$144M	1.88%	3

Other funds holding AZN

Evelyn Partners London $46.9B AUM

Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Cambiar Investors's AZN Position: Q2 2026 in Review

Cambiar Investors reduced its AstraZeneca (AZN) stake by 2.8% in Q2 2026, selling an estimated $696K and leaving 129,899 shares worth $24.6M. The position accounts for 1.07% of the portfolio, ranked #43.

Cambiar Investors first reported a position in AZN in Q2 2015 and has held it in 11 quarters since. The position peaked at $233M in Q4 2015. 1,495 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

Cambiar Investors held 129,899 shares of AstraZeneca worth $24.6M as of Q2 2026.
Cambiar Investors sold 3,700 AstraZeneca shares in Q2 2026, an estimated $696K.
AstraZeneca made up 1.07% of Cambiar Investors's portfolio in Q2 2026, its #43 holding.
Cambiar Investors first reported a position in AstraZeneca in Q2 2015 and has held it in 11 quarters since.
Cambiar Investors's AstraZeneca position peaked at $233M in Q4 2015.
1,495 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Cambiar Investors's 13F filing for Q2 2026, filed 31 Jul 2026.